Clinical Trial Update: TXA vs. Amicar in Total Knee and Hip Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing tranexamic acid (TXA) vs. Amicar in total knee and hip arthroplasty; trial completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss
• Hip Arthritis
• Knee Arthritis

Drugs mentioned

• Amicar (aminocaproic acid)
• TXA (tranexamic acid)

Snippet

Sponsor: Duke University | Conditions: Blood Loss, Hip Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2018-12-05